Tonsil-derived mesenchymal stem cells enhance allogeneic bone marrow engraftment via collagen IV degradation.
Hyun-Ji LeeYu-Hee KimDa-Won ChoiKyung-Ah ChoJoo-Won ParkSang-Jin ShinInho JoSo-Youn WooKyung-Ha RyuPublished in: Stem cell research & therapy (2021)
Collectively, these results indicate that TMSCs enhance BMC engraftment by the secretion of MMP3 for the modulation of the bone marrow extracellular matrix.